Delivery Order SPE2DB20D2104-SPE2DB22FR97G
- Not listed
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is for the delivery of 500 tablets of Felodipine extended-release 10 milligram tablets, a generic pharmaceutical product. The potential value of the order is $1,297.79 and the performance period extends through March 7, 2024. No set-aside designation was used for this award. AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a $11,891.64 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562056184 felodipine ER 10 mg tablets (100 count). As the prime contractor, Amerisourcebergen will deliver the generic hypertension medication to a facility in Conshohocken, Pennsylvania by September 6, 2023 to support DLA's medical supply needs. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation, which will perform as the prime...
- This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,045.24 firm fixed-price delivery order is for the supply of 4,566,121,250 tablets of Nifedipine ER 30 mg, a cardiovascular medication. The contract has an ultimate completion date of October 17, 2024. There was no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999...
- This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $10,490.93 firm fixed-price contract is for the delivery of pharmaceutical and medical products, including medications across multiple therapeutic domains such as diabetes, neurology, pain management, and others. The contract is not set aside and allows for multiple delivery orders to support federal medical...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $37,492.76, is a firm-fixed-price delivery order with an ultimate completion date of April 29, 2025. The contract provides for the delivery of a variety of pharmaceutical products and medical supplies, including medications across multiple therapeutic domains such as diabetes, neurology,...
- This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00. The delivery order, worth $16,554.44, is for the supply of various pharmaceutical and medical products, including medications across multiple therapeutic domains such as diabetes, neurology, pain management, and antibiotics, as well as specialized medical supplies. The contract is...
- This is a $37,689.12 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of a variety of pharmaceutical products and medical supplies, including medications across multiple therapeutic categories such as diabetes treatments, neurological medications, pain management pharmaceuticals, and specialized medical supplies. This delivery order...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $814,359.39 contract is for the delivery of a variety of pharmaceutical products and medical supplies, including medications across multiple therapeutic areas such as diabetes, neurology, pain management, and more. This order is placed under Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $813,775.45 contract is for the delivery of a variety of pharmaceutical products and medical supplies, including medications across multiple therapeutic domains such as diabetes, neurology, pain management, and specialized treatments. This delivery order is part of a larger Indefinite Delivery Contract...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of various pharmaceutical and medical products. The contract, valued at $1,168.50, is a firm fixed-price delivery order without a set-aside designation, indicating open competition. The products being delivered include medications across multiple therapeutic areas such as diabetes, neurology, pain management, and specialty pharmaceuticals....
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB22FR97GDelivery Order
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 500 tablets of Felodipine extended-release 10 mg. The contract has a firm fixed price of $1,406.54 and a completion date of March 3, 2022. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare programs globally. The contract award did not have a set-aside designation, indicating open competition. AmerisourceBergen's parent company is Cencora, Inc., which also holds a separate IDC with the Department of Justice Federal Bureau of Investigation valued at up to $750,000 for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 3/2/22 |